FDA inspection

Sri Krishna Pharmaceuticals, Ltd. - Unit III: FDA inspection ending Jul 31, 2023

FDA inspection 1216334 · Voluntary Action Indicated (VAI) · Ranga Reddy District

Key facts

Inspection ID 1216334
Firm Sri Krishna Pharmaceuticals, Ltd. - Unit III
FEI number 3005403224
Address Survey No. 57, Golkonda Kalan, Raikunta Village, Shamshabad Mandal
City Ranga Reddy District
Country India
Fiscal year 2023
Inspection end date Jul 31, 2023
Classification Voluntary Action Indicated (VAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections